Press Releases

Webcast
T2 Biosystems Inc. at the Cantor Fitzgerald Global Healthcare Conference (Live)
Monday, September 25, 2017 10:55 am EDT
Date Title
11/27/17
Summary ToggleT2 Biosystems to Attend the Global Mizuho Investor Conference Printer Friendly Version LEXINGTON, Mass. , Nov. 27, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, today announced that John McDonough , president and chief executive officer, and Darlene Deptula-Hicks , SVP
11/20/17
Summary ToggleT2 Biosystems Announces New T2Bacteria RUO Panel Data Presented at AMP 2017 Printer Friendly Version Results Show Detection of Clinically Important Infections Missed by Blood Culture LEXINGTON, Mass. , Nov. 20, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, today announced new data
11/09/17
Summary ToggleT2 Biosystems Announces Presentation on T2Sepsis Solution at AMP 2017 Printer Friendly Version LEXINGTON, Mass. , Nov. 09, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today announced a workshop presentation on the T2Sepsis Solution™ during the Association for Molecular Pathology
11/02/17
Summary ToggleT2 Biosystems Reports Third Quarter 2017 Financial Results and Provides Company Update Printer Friendly Version Submitted 510(k) Application to the FDA Requesting Market Clearance for T2Bacteria Panel Year over Year Quarterly Product Revenue Growth of 27.4% LEXINGTON, Mass. , Nov. 02, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic
11/01/17
Summary ToggleT2 Biosystems to Attend the Canaccord Medical Technologies and Diagnostics Forum Printer Friendly Version LEXINGTON, Mass. , Nov. 01, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development of innovative diagnostic products to improve patient health, today announced that John McDonough , president and chief executive officer, and Darlene Deptula-Hicks , SVP and
10/16/17
Summary ToggleT2 Biosystems Announces 2017 Third Quarter Financial and Operational Results Release and Conference Call Date Printer Friendly Version LEXINGTON, MA , Oct. 16, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development of innovative diagnostic products to improve patient health, today announced that it will release its 2017 third quarter financial and operational results after the market
10/12/17
Summary ToggleClinicians Discuss Positive Impact of T2MR Platform on Sepsis Care at IDWeek 2017 Printer Friendly Version Clinicians present clinical and economic value of the T2Sepsis Solution and discuss potential of T2Bacteria Panel LEXINGTON, Mass., Oct. 12, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health,
10/03/17
Summary ToggleStudy Published in Journal of Antimicrobial Stewardship Shows Patients Diagnosed with T2Candida Panel Treated More Than Eight Times Faster Printer Friendly Version T2MR platform shown to lead to appropriate therapy in 5 hours compared to 44 hours based on blood culture LEXINGTON, Mass. , Oct. 03, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today
09/21/17
Summary ToggleT2 Biosystems Announces Presentations at IDWeek 2017 Printer Friendly Version LEXINGTON, MA, September 21, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today announced a panel presentation and six poster presentations during the IDWeek 2017 Conference in San
09/18/17
Summary ToggleT2 Biosystems to Present at the Cantor Fitzgerald Global Healthcare Conference Printer Friendly Version LEXINGTON, Mass. , Sept. 18, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today announced that John McDonough , president and chief executive officer, and Darlene Deptula-Hicks , SVP